Answers are grounded in this paper and cite their sources.
Synthesis reveals luminescent properties of terbium carbazolate in nanoparticles, indicating potential applications.
Zerovalent Terbium metal nanoparticles are prepared in the liquid phase by reduction of TbCl 3 with lithium naphthalenide ([LiNaph]) in THF. The as‐prepared Tb(0) nanoparticles are monocrystalline with small and uniform size of 2.8 ± 0.4 nm. Although the deep black Tb(0) nanoparticle suspension is colloidally and chemically stable in THF under inert conditions, it shows high reactivity when in contact with O 2 , H 2 O, or other oxidizing agents. The high reactivity can be used to react Tb(0) nanoparticles with carbazole (cbzH) as a sterically demanding N–H‐acidic amine. As a result, Terbium carbazolate with a composition [Tb(cbz) 3 (THF) 2 ](cbzH)(C 7 H 8 ) ( 1 ) is obtained upon oxidation of Terbium and formation of H 2 . Herein, Tb 3+ is coordinated by three deprotonated, negatively charged (cbz) – ligands and two molecules of THF. Already in daylight, 1 shows Tb 3+ ‐driven emission of green light with cbz serving as an antenna for excitation. The Tb(0) nanoparticles and the Terbium carbazolate 1 are characterized by transmission electron microscopy, electron diffraction, Fourier transform infrared spectroscopy, crystal‐structure analysis, and photoluminescence spectroscopy.
No takes yet. Share an insight, caveat, or question.
Reiß et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: